Q4 2024 Hester Biosciences Ltd Earnings Call Transcript
Key Points
- Hester Biosciences Ltd (BOM:524669) achieved a significant milestone by reaching the INR300 crore revenue mark, with consolidated revenue up by 18% quarter-on-quarter and 14% year-on-year.
- The Animal Health division showed resilience with a 12% quarter-on-quarter and 8% year-on-year growth despite regulatory challenges.
- The Poultry Healthcare division experienced a robust 22% growth in Q4, driven by industry recovery and strategic product introductions.
- The company successfully reduced its debt by INR30 crore, reflecting prudent financial management.
- Hester Biosciences Ltd (BOM:524669) received the final milestone grant payment from BIRAC, enhancing its manufacturing capacity for veterinary vaccines.
- The company faced challenges due to regulatory changes, leading to the discontinuation of two brands in the Animal Health division.
- There was a slight sales dip in the Healthcare division in Q4 compared to the corresponding quarter.
- Hester Africa reported a net loss of INR18 crore for the year, impacted by macroeconomic factors and foreign exchange losses.
- The company is still in the process of developing and commercializing new products, which may take time to generate significant revenue.
- The dairy sector's growth is slow due to the fragmented nature of the industry and the need for consolidation and increased vaccination efforts.
Ladies and gentlemen, good day, and welcome to Hester Biosciences Limited Q4 FY24 and FY24 financial results conference call hosted by ICICI Securities. (Operator Instructions)
Please note that this conference is being recorded, and I'll hand the conference over to Mr. Abdul Kader Puranwala sir, thank you and over to you.
Yeah, on behalf of ICICI Securities, I welcome you all on the Q4 FY24 earnings conference call of Hester Biosensors and I thank you Hester Biosciences management team for giving us this opportunity to host this call.
Today, on this call, we have with us Mr. Rajiv Gandhi CEO and Managing Director; Ms. Priya Gandhi Executive Director; Mr. Nikhil Jhanwar CFO. I will now hand over the call to the Hester management team for their opening remarks. Thank you.
Good afternoon, everyone. This is Priya Gandhi, I'm happy to have you all here for our quarterly update for Q4 FY24. We believe
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
